As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
An optimal PSA response, defined as ≤0.2 ng/mL, is achieved by approximately 51% of mHSPC patients 6–8 months after treatment with androgen deprivation therapy (ADT) and androgen receptor pathway ...
David Trafimow, a Distinguished Achievement professor of psychology at New Mexico State University, was recently selected to receive the prestigious Humboldt Research Award for 2026. Scott Brocato ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results